Tips

四月JDB电子将主办3场线上直播，同时参加5场行业会议，等待与各位业内同仁互换分享药物研发新趋向。

第6届BIONNOVA生物医药创新者论坛暨展览会

2025年4月9-10日，第6届BIONNOVA生物医药创新者论坛暨展览会诚邀新老伴侣再次相约上海张江科学会堂，与10000+生物医药全产业链创新实际者同筑新程!

JDB电子生物技术药物分析部掌管人章登吉博士将受邀出席，并在4月9日“抗体偶联药物前沿索求”论坛分享：从CRO视角看ADC/XDC类药物研发趋向及对临床前钻研的分析挑战。

JDB电子团队将在T02号展位，期待您的莅临互换！

20th Annual Drug Discovery Chemistry

Optimizing Small Molecules for Tomorrow’s Therapeutics
Medicilon Booth #510

Medicilon offers comprehensive drug discovery services, encompassing medicinal and synthetic chemistry, along with biology expertise. We empower pharmaceutical, biotech, and academic researchers to accelerate small molecule drug candidate discovery and optimization. Leveraging FTE and FFS models, we provide integrated chemistry research services and employ cutting-edge technologies like AI, PROTAC, and ADC technology to efficiently advance projects, control costs, and ensure superior quality.

AACR 2025

Medicilon is excited to exhibit at the AACR Annual Meeting, a premier forum for cancer research advances. Meet Dr. Qingcong Lin, President of Medicilon USA Corp., Dr. Lilly Xu, CTO of Medicilon, and Dr. Baohong Cao, VP of Pharmacology. 

Dr. Weizhong Zhang will present a Medicilon poster on "Developing PDX-Derived Organoid Models for Efficacy Evaluation of Anticancer Therapies" on Sunday, April 27, from 2:00 PM-5:00 PM, Poster #26, Section 2.

Join Medicilon at booth #3740 to discuss your research needs. 

Nordic Precision Medicine Forum 2025

Nordic Precision Medicine Forum brings four tracks under one roof. The multi topic forum is dedicated to advancing the diagnosis, prognosis and treatment of disease across the Nordics. Bringing together those leading the move towards more personalised approaches, Nordic Precision Medicine Forum is considered the meeting for the region. Benefiting from insight on Nordic and international initiatives, attendees of Nordic Precision Medicine Forum will have the opportunity to come together, ask questions, problem solve and network with key opinion leaders in Precision Medicine and the fields of oncology and pathology. 

Medicilon is excited to attend and exhibit at the conference. Dr. Paul G.J. van Stralen, VP Strategic Collaborations EMEA at Medicilon, will be available at the conference. We look forward to greeting you in Stockholm! 

18th Drug Discovery Strategic Summit

18th Drug Discovery Strategic Summit (DDSS) is designed to ignite business innovation and foster progress. Grounded in deep industry expertise and shaped by client insights. Where Innovation Meets Opportunity: Exclusive Summits for Drug Discovery Leaders. 

Medicilon will exhibit at the 18th DDSS. Medicilon's drug discovery services integrate chemistry and biology, offering custom synthesis, compound library construction, SAR compound synthesis and screening, and compound structure and biological activity optimization. Our medicinal chemistry team utilizes computational chemistry to enhance compound design and incorporates advanced technologies to efficiently deliver high-quality results while controlling costs.

marketing@medicilon.com.cn
媒体与会务请联系
JDB电子市场部微信或邮箱